Scout | NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

This grant opportunity invites applications for early-stage clinical trials related to neurological disorders and stroke, supported by the National Institute of Neurological Disorders and Stroke (NINDS). It focuses on Phase 1 and 2 studies of drugs and biologics, feasibility studies of devices, and early-stage research on surgical, behavioral, or rehabilitation therapies. The goal is to gather…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Dates

Opportunity Released: November 12, 2024

Open for Submission: November 12, 2024

Submission Deadline: March 10, 2025

Application Window Closes: March 10, 2025

Keywords

exploratory clinical trials

neurological disorders

NINDS

Phase 1 trial

Phase 2 trial

drugs and biologics

feasibility studies

surgical therapies

behavioral therapies

rehabilitation therapies

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers